National Cancer Institute Funds Second Year Of Grant To Guided Therapeutics To Commercialize Non-invasive Cervical Cancer Detection Device
Main Category: Cervical Cancer / HPV VaccineAlso Included In: Medical Devices / Diagnostics
Article Date: 26 Aug 2010 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Guided Therapeutics, Inc. (GT) (OTCBB: GTHP) announced that it was awarded $1.0 million to fund the second year of a $2.5 million grant from the National Cancer Institute (NCI) announced in 2009.
The three-year grant provides additional resources to commercialize and bring to market the LightTouch™ non-invasive cervical cancer detection device and single-patient-use disposable.
"The continuation of the grant provides additional non-dilutive resources for us to complete the regulatory process, include design enhancements and begin manufacturing LightTouch devices and disposables," said Mark L. Faupel, Ph.D., President and CEO of GT. "We believe that the award continuation also indicates a high level of confidence in our technology by the NCI reviewers."
GT has been awarded approximately $6 million in six consecutive grants from the NCI to develop the new, pain-free test for detecting cervical disease.
The GT LightTouch technology scans the cervix with light to identify cancer and pre-cancer painlessly and non-invasively. The technology distinguishes between normal and diseased tissue, by detecting biochemical and morphological changes at the cellular level. Unlike Pap or HPV tests, the LightTouch test does not require a tissue sample or laboratory analysis, and is designed to provide results immediately. The technology is designed as a device employing a single-use disposable patient interface.
Results of a multi-center pivotal clinical trial showed that LightTouch detected cervical disease up to two years earlier than Pap test, HPV test, colposcopy and biopsy. The LightTouch is designed to detect disease early, when treatment is most effective, and to eliminate unnecessary testing saving the healthcare system money.
Source:
Guided Therapeutics
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/198944.php>
APA
http://www.medicalnewstoday.com/releases/198944.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



